Biomarin Pharmaceutical Inc (BMRN)

BMRN (NASDAQ:Drugs) EQUITY
$129.20
pos +0.42
+0.33%
Today's Range: 126.54 - 133.44 | BMRN Avg Daily Volume: 1,431,300
Last Update: 03/30/15 - 3:59 PM EDT
Volume: 2,821,165
YTD Performance: 42.46%
Open: $131.33
Previous Close: $128.78
52 Week Range: $55.04 - $133.54
Oustanding Shares: 159,135,697
Market Cap: 18,388,129,788
6-Month Chart
TheStreet Ratings Grade for BMRN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 11 11
Moderate Buy 1 1 1 1
Hold 3 3 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.44 1.44 1.47 1.56
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -125.60
Price Earnings Comparisons:
BMRN Sector Avg. S&P 500
-125.60 0.00 27.26
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
40.70% 86.88% 267.73%
GROWTH 12 Mo 3 Yr CAGR
Revenue 36.90 0.70 0.19
Net Income 0.00 1.49 0.00
EPS 0.00 0.92 0.00
Earnings for BMRN:
EBITDA -0.10B
Revenue 0.75B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $-0.54 $-0.55 $-2.26 $-1.19
Number of Analysts 9 9 12 11
High Estimate $-0.27 $-0.33 $-1.53 $0.07
Low Estimate $-0.64 $-0.65 $-2.65 $-2.45
Prior Year $-0.27 $-0.19 $-0.77 $-2.26
Growth Rate (Year over Year) -98.35% -189.47% -193.29% 47.19%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Here are healthcare stocks of all shares and sizes with strong charts.
An answer to those asking me what's worth buying.
You can't help but feel better about both groups.
Own them, or take something off the table?
A Fed-related dip may be your only hope to get in lower.
These companies are doing great -- take some profits!
It shouldn't be possible, but it never seems too late to get in.
Stocks that stabilized yesterday were terrific today.
Sector could regain its leadership role.
Watch this leadership group that's been lagging.

Columnist Conversations

Good closing piece by "El Capitan" on the nature of buyers these days. I totally agree. As I have recently wri...
I have covered my small SPY short that I put on today after the close at about $208.03 for a breakeven on the ...
The fact that Twitter (TWTR) "bears" had a chance to inflict more serious damage by pressing TWTR further belo...
Since this is a shortened Holiday week I dont plan to issue another "trade of the week" - beyond the short bon...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.